1-4 of 4
Wenqiang Xie
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Addition of Daclizumab to Standard Graft-Versus-Host Disease Prophylaxis in Patients with Thalassemia Major Undergoing Transplantation from Alternative Donor Hematopoietic Stem-Cell Transplantation: A Single-Center Retrospective Analysis from China

Cuifeng Huang, Gaohui Yang, Lingling Shi, Lianjin Liu, Zhongming Zhang, Zhenbin Wei, Beicai Liu, Zhaoping Gan, Wenqiang Xie, Rui Huang, Na Sun, Meiqing Wu, Xuemei Zhou, Yinghua Chen, Yanye Liu, Zhi Li, Zhaofang Pan, Huicheng Huang, Qifa Liu, Rongrong Liu, Yongrong Lai
Journal: Blood
Blood (2024) 144 (Supplement 1): 2152.
https://doi.org/10.1182/blood-2024-205021
Published: 2024
Journal Articles

Safety and Efficacy of RM-001 (Autologous HBG1/2 Promoter-modified CD34+ Hematopoietic Stem and Progenitor Cells) in Patients with Transfusion-Dependent β-Thalassemia

Rongrong Liu, Li Wang, Hui Xu, Xiaolin Yin, Junbin Liang, Wenqiang Xie, Gaohui Yang, Yaoyun Li, Yali Zhou, Lei Shi, Bin Xiao, Lingling Shi, Zeyan Shi, Xuemei Zhou, Xiangmin Xu, Jianpei Fang, Yongrong Lai, Junjiu Huang, Xinhua Zhang
Journal: Blood
Blood (2023) 142 (Supplement 1): 4994.
https://doi.org/10.1182/blood-2023-181453
Published: 2023
Journal Articles

Addition of Daclizumab to Standard Graft-Versus-Host Disease Prophylaxis in Patients with Thalassemia Major Undergoing Transplantation from Related Haploidentical Donor and Unrelated Donor Hematopoietic Stem-Cell Transplantation: A Single-Center Retrospective Analysis from China

Rongrong Liu, Gaohui Yang, Lingling Shi, Lianjin Liu, Zhongming Zhang, Cuifeng Huang, Zhenbin Wei, Beicai Liu, Zhaoping Gan, Wenqiang Xie, Rui Huang, Na Sun, Shuyi Wei, Xuemei Zhou, Yinghua Chen, Yanye Liu, Zhi Li, Qifa Liu, Yongrong Lai
Journal: Blood
Blood (2023) 142 (Supplement 1): 5252.
https://doi.org/10.1182/blood-2023-180056
Published: 2023
Journal Articles

Preliminary Result of the Safety and Efficacy of Autologous HBG1/2 Promoter-Modified CD34+ Hematopoietic Stem and Progenitor Cells (RM-001) in Transfusion-Dependent Βeta-Thalassemia

Rongrong Liu, Hui Xu, Junbin Liang, Wenqiang Xie, Gaohui Yang, Lei Shi, Lingling Shi, Jianpei Fang, Chunfu Li, Zeyan Shi, Xuemei Zhou, Junjiu Huang, Yongrong Lai
Journal: Blood
Blood (2022) 140 (Supplement 1): 4915–4916.
https://doi.org/10.1182/blood-2022-169151
Published: 2022